Viewing Study NCT04129320

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:29 AM
Ignite Modification Date: 2026-01-29 @ 7:57 AM
Study NCT ID: NCT04129320
Status: WITHDRAWN
Last Update Posted: 2022-02-08
First Post: 2019-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
Sponsor: MacroGenics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
None Squamous Cell Carcinoma of Head and Neck View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SCCHN View
None head and neck View
None oropharyngeal View
None oral cavity View
None hypopharyngeal View
None laryngeal cancer View
None immunotherapy View
None PD-1 View
None B7-H3 View
None LAG-3 View